Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 67

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 67
---
5, based in part on the unanimous recommendation of the Transaction Committee and with the advice and assistance of its independent legal and financial advisors, as well as on the basis of the other factors described under the heading “ Reasons for the Arrangement,” the Board:

| • |     | determined unanimously that the Arrangement is in the best interests of the Company and is fair to the 
 Shareholders;                                                                                          |

| • |     | authorized and approved unanimously the Arrangement and the Agreement, and the Company’s entrance into the 
 Agreement and the performance by the Company of its obligations thereunder;                                |

| • |     | determined unanimously that the Arrangement Resolution shall be submitted for the consideration of the 
 Shareholders at the Special Meeting; and                                                               |

| • |     | unanimously recommends that the Shareholders vote “FOR” the Arrangement Resolution. |

Opinion of Leerink Partners Unless the context requires otherwise, capitalized terms used but not defined in this “Opinion of Leerink Partners” section shall have the meaning ascribed to such term in Annex B. Introduction Repare retained Leerink Partners as its financial advisor in connection with the transactions contemplated by the Agreement (which are referred to in this Section as the “Transaction”). In connection with this engagement, the Repare Board requested that Leerink Partners evaluate the fairness, from a financial point of view, to the holders of Shares (other than Excluded Shares (as defined below)) of the Cash Consideration (as defined below) proposed to be paid to such holders pursuant to the Arrangement contemplated by the Agreement. For purposes of this summary of Leerink Partners’ opinion: (a) “Excluded Shares” means Common Shares held by a Dissenting Shareholder in respect of which Dissent Rights have been validly exercised under the Plan of Arrangement, the Purchaser or any affiliate of the Purchaser; and (b) “Cash Consideration” means an amount per Common Share equal to the sum of (A) the “Cash Amount,” or the Closing Net Cash as of the Cash Determination Time, divided by the Company Outstanding Shares, plus (B) (i) the Incentive Securities Cash Balance divided by (ii) the number of issued and outstanding Common Shares as at immediately prior to the Effective Time. On November 14, 2025, Leerink Partners rendered to the Repare Board its oral opinion, which was subsequently confirmed by delivery of a written opinion dated November 14, 2025, that, as of such date and based upon and